These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

397 related items for PubMed ID: 21709080

  • 1. Activity of ceftaroline and epidemiologic trends in Staphylococcus aureus isolates collected from 43 medical centers in the United States in 2009.
    Richter SS, Heilmann KP, Dohrn CL, Riahi F, Costello AJ, Kroeger JS, Biek D, Critchley IA, Diekema DJ, Doern GV.
    Antimicrob Agents Chemother; 2011 Sep; 55(9):4154-60. PubMed ID: 21709080
    [Abstract] [Full Text] [Related]

  • 2. Antimicrobial susceptibility and molecular typing of MRSA in cystic fibrosis.
    Champion EA, Miller MB, Popowitch EB, Hobbs MM, Saiman L, Muhlebach MS, STAR-CF Study Team.
    Pediatr Pulmonol; 2014 Mar; 49(3):230-7. PubMed ID: 23765686
    [Abstract] [Full Text] [Related]

  • 3. Molecular characterization and antibiotic resistance of clinical isolates of methicillin-resistant Staphylococcus aureus obtained from Southeast of Iran (Kerman).
    Sadeghi J, Mansouri S.
    APMIS; 2014 May; 122(5):405-11. PubMed ID: 24033803
    [Abstract] [Full Text] [Related]

  • 4. Antimicrobial activity of ceftaroline tested against staphylococci with reduced susceptibility to linezolid, daptomycin, or vancomycin from U.S. hospitals, 2008 to 2011.
    Sader HS, Flamm RK, Jones RN.
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3178-81. PubMed ID: 23629712
    [Abstract] [Full Text] [Related]

  • 5. Activity analyses of staphylococcal isolates from pediatric, adult, and elderly patients: AWARE Ceftaroline Surveillance Program.
    Sader HS, Flamm RK, Farrell DJ, Jones RN.
    Clin Infect Dis; 2012 Sep; 55 Suppl 3():S181-6. PubMed ID: 22903950
    [Abstract] [Full Text] [Related]

  • 6. Comparison of methicillin-resistant Staphylococcus aureus strains isolated in 2003 and 2008 with an emergence of multidrug resistant ST22: SCCmec IV clone in a tertiary hospital, Malaysia.
    Lim KT, Hanifah YA, Mohd Yusof MY, Ito T, Thong KL.
    J Microbiol Immunol Infect; 2013 Jun; 46(3):224-33. PubMed ID: 23523045
    [Abstract] [Full Text] [Related]

  • 7. [Epidemiological and molecular characteristics of hospital-acquired methicillin-resistant Staphylococcus aureus strains isolated in Hacettepe University Adult Hospital in 2004-2005].
    Akoğlu H, Zarakolu P, Altun B, Ünal S.
    Mikrobiyol Bul; 2010 Jul; 44(3):343-55. PubMed ID: 21063984
    [Abstract] [Full Text] [Related]

  • 8. Characterization of methicillin-resistant Staphylococcus aureus strains recovered from a phase IV clinical trial for linezolid versus vancomycin for treatment of nosocomial pneumonia.
    Mendes RE, Deshpande LM, Smyth DS, Shopsin B, Farrell DJ, Jones RN.
    J Clin Microbiol; 2012 Nov; 50(11):3694-702. PubMed ID: 22972817
    [Abstract] [Full Text] [Related]

  • 9. In vitro susceptibilities and molecular analysis of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus isolates.
    Saravolatz LD, Pawlak J, Johnson LB.
    Clin Infect Dis; 2012 Aug; 55(4):582-6. PubMed ID: 22615331
    [Abstract] [Full Text] [Related]

  • 10. Activity of ceftobiprole against methicillin-resistant Staphylococcus aureus strains with reduced susceptibility to daptomycin, linezolid or vancomycin, and strains with defined SCCmec types.
    Farrell DJ, Flamm RK, Sader HS, Jones RN.
    Int J Antimicrob Agents; 2014 Apr; 43(4):323-7. PubMed ID: 24411474
    [Abstract] [Full Text] [Related]

  • 11. Methicillin-resistant Staphylococcus aureus in Stockholm, Sweden: Molecular epidemiology and antimicrobial susceptibilities to ceftaroline, linezolid, mupirocin and vancomycin in 2014.
    Fang H, Fröding I, Gian B, Hæggman S, Tollström UB, Ullberg M, Nord CE.
    J Glob Antimicrob Resist; 2016 Jun; 5():31-5. PubMed ID: 27436463
    [Abstract] [Full Text] [Related]

  • 12. Simulated antibiotic exposures in an in vitro hollow-fiber infection model influence toxin gene expression and production in community-associated methicillin-resistant Staphylococcus aureus strain MW2.
    Pichereau S, Pantrangi M, Couet W, Badiou C, Lina G, Shukla SK, Rose WE.
    Antimicrob Agents Chemother; 2012 Jan; 56(1):140-7. PubMed ID: 22064533
    [Abstract] [Full Text] [Related]

  • 13. Ceftaroline-heteroresistant Staphylococcus aureus.
    Saravolatz SN, Martin H, Pawlak J, Johnson LB, Saravolatz LD.
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3133-6. PubMed ID: 24637680
    [Abstract] [Full Text] [Related]

  • 14. Antimicrobial susceptibility profiles of meticillin-susceptible and -resistant Staphylococcus aureus: focus on daptomycin minimum inhibitory concentrations at a tertiary care centre in Mumbai, India.
    D'Souza N, Shetty A, Mehta A, Rodrigues C.
    Int J Antimicrob Agents; 2010 Sep; 36(3):267-70. PubMed ID: 20594809
    [Abstract] [Full Text] [Related]

  • 15. Characterization of baseline methicillin-resistant Staphylococcus aureus isolates recovered from phase IV clinical trial for linezolid.
    Mendes RE, Sader HS, Deshpande LM, Diep BA, Chambers HF, Jones RN.
    J Clin Microbiol; 2010 Feb; 48(2):568-74. PubMed ID: 19940054
    [Abstract] [Full Text] [Related]

  • 16. Methicillin-resistant S. aureus infections among patients in the emergency department.
    Moran GJ, Krishnadasan A, Gorwitz RJ, Fosheim GE, McDougal LK, Carey RB, Talan DA, EMERGEncy ID Net Study Group.
    N Engl J Med; 2006 Aug 17; 355(7):666-74. PubMed ID: 16914702
    [Abstract] [Full Text] [Related]

  • 17. In vitro activity of novel anti-MRSA cephalosporins and comparator antimicrobial agents against staphylococci involved in prosthetic joint infections.
    Isnard C, Dhalluin A, Malandain D, Bruey Q, Auzou M, Michon J, Giard JC, Guérin F, Cattoir V.
    J Glob Antimicrob Resist; 2018 Jun 17; 13():221-225. PubMed ID: 29421316
    [Abstract] [Full Text] [Related]

  • 18. Nationwide surveillance of resistance rates of Staphylococcus aureus clinical isolates from Greek hospitals, 2012-2013.
    Souli M, Karaiskos I, Galani L, Maraki S, Perivolioti E, Argyropoulou A, Charissiadou A, Zachariadou L, Tsiplakou S, Papaioannou V, Tsorlini H, Katsifa H, Baka V, Pantazi P, Paschali A, Kyratsa A, Trikka-Graphakos E, Giannopoulou P, Vogiatzakis E, Moraitou H, Papadogeorgaki H, Avgerinou H, Panagea T, Pantazatou A, Petinaki E, Stamatopoulou G, Toutouza M, Karatzoglou I, Kontopoulou K, Orfanidou M, Karantani I, Fytas P, Tzanetou K, Platsouka E, Kazila P, Chli A, Statiri N, Giamarellou H.
    Infect Dis (Lond); 2016 Apr 17; 48(4):287-292. PubMed ID: 26635179
    [Abstract] [Full Text] [Related]

  • 19. Characterisation of clinical isolates of oxacillin-susceptible mecA-positive Staphylococcus aureus in China from 2009 to 2014.
    Song Y, Cui L, Lv Y, Li Y, Xue F.
    J Glob Antimicrob Resist; 2017 Dec 17; 11():1-3. PubMed ID: 28729204
    [Abstract] [Full Text] [Related]

  • 20. Activity of ceftaroline against extracellular (broth) and intracellular (THP-1 monocytes) forms of methicillin-resistant Staphylococcus aureus: comparison with vancomycin, linezolid and daptomycin.
    Mélard A, Garcia LG, Das D, Rozenberg R, Tulkens PM, Van Bambeke F, Lemaire S.
    J Antimicrob Chemother; 2013 Mar 17; 68(3):648-58. PubMed ID: 23188792
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.